CO
Carmine T Oliva
CEO and ChairmanDirector

Carmine T Oliva insider trades: EMRISE (EMRI) stock purchases

CEO and Chairman, EMRISE Last trade Jun 7, 2013 19 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
16
Open-market trades
since 2006
2
Companies
last trade 2013

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Carmine reports to the SEC

Open-market buys and sales

16 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 7, 2013EMRI↑ Buy$3K
Dec 11, 2012EMRI↑ Buy$5K
Sep 13, 2012EMRI↑ Buy$3K
Dec 15, 2011EMRI↑ Buy$1K
Nov 30, 2011EMRI↑ Buy$1K
Nov 18, 2011EMRI↑ Buy$570
Nov 18, 2011EMRI↑ Buy$1K
Sep 15, 2011EMRI↑ Buy$650
Sep 14, 2011EMRI↑ Buy$2K
Aug 31, 2011EMRI↑ Buy$2K
Sep 17, 2010ERI↑ Buy$5K
Sep 15, 2010ERI↑ Buy$3K
Sep 13, 2010ERI↑ Buy$9K
Jun 2, 2008ERI↑ Buy$56K
May 23, 2007ERI↑ Buy$11K
Apr 24, 2006ERI↑ Buy$15K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Carmine T Oliva's insider trades

Carmine T Oliva is CEO and Chairman at EMRISE (EMRI). Since Apr 24, 2006, Carmine has reported 16 open-market purchases worth $118K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EMRI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.